313 related articles for article (PubMed ID: 30719508)
1. Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen.
Harrop R; O'Neill E; Stern PL
Ther Adv Vaccines Immunother; 2019; 7():2515135518821623. PubMed ID: 30719508
[TBL] [Abstract][Full Text] [Related]
2. 5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
Stern PL; Harrop R
Cancer Immunol Immunother; 2017 Apr; 66(4):415-426. PubMed ID: 27757559
[TBL] [Abstract][Full Text] [Related]
3. Oncofetal proteins and cancer stem cells.
Yan Q; Fang X; Li C; Lan P; Guan X
Essays Biochem; 2022 Sep; 66(4):423-433. PubMed ID: 35670043
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine-Conjugated Antibody-Drug Conjugate Targeting 5T4.
Harper J; Lloyd C; Dimasi N; Toader D; Marwood R; Lewis L; Bannister D; Jovanovic J; Fleming R; D'Hooge F; Mao S; Marrero AM; Korade M; Strout P; Xu L; Chen C; Wetzel L; Breen S; van Vlerken-Ysla L; Jalla S; Rebelatto M; Zhong H; Hurt EM; Hinrichs MJ; Huang K; Howard PW; Tice DA; Hollingsworth RE; Herbst R; Kamal A
Mol Cancer Ther; 2017 Aug; 16(8):1576-1587. PubMed ID: 28522587
[TBL] [Abstract][Full Text] [Related]
5. CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells.
Southgate TD; McGinn OJ; Castro FV; Rutkowski AJ; Al-Muftah M; Marinov G; Smethurst GJ; Shaw D; Ward CM; Miller CJ; Stern PL
PLoS One; 2010 Apr; 5(4):e9982. PubMed ID: 20376365
[TBL] [Abstract][Full Text] [Related]
6. Effective antitumor activity of 5T4-specific CAR-T cells against ovarian cancer cells in vitro and xenotransplanted tumors in vivo.
Guo C; Dong E; Lai Q; Zhou S; Zhang G; Wu M; Yue X; Tao Y; Peng Y; Ali J; Lu Y; Fu Y; Lai W; Zhang Z; Ma F; Yao Y; Gou L; Yang H; Yang J
MedComm (2020); 2020 Dec; 1(3):338-350. PubMed ID: 34766126
[TBL] [Abstract][Full Text] [Related]
7. Understanding and exploiting 5T4 oncofoetal glycoprotein expression.
Stern PL; Brazzatti J; Sawan S; McGinn OJ
Semin Cancer Biol; 2014 Dec; 29():13-20. PubMed ID: 25066861
[TBL] [Abstract][Full Text] [Related]
8. Update on immune-based therapy strategies targeting cancer stem cells.
Izadpanah A; Mohammadkhani N; Masoudnia M; Ghasemzad M; Saeedian A; Mehdizadeh H; Poorebrahim M; Ebrahimi M
Cancer Med; 2023 Sep; 12(18):18960-18980. PubMed ID: 37698048
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
10. 5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells.
Guo X; Zheng H; Luo W; Zhang Q; Liu J; Yao K
Sci Rep; 2017 Jul; 7(1):4859. PubMed ID: 28687750
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in drug delivery systems for targeting cancer stem cells.
Duan H; Liu Y; Gao Z; Huang W
Acta Pharm Sin B; 2021 Jan; 11(1):55-70. PubMed ID: 33532180
[TBL] [Abstract][Full Text] [Related]
12. Novel therapeutic strategies for targeting liver cancer stem cells.
Oishi N; Wang XW
Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis.
Kapoor-Narula U; Lenka N
Cytokine; 2022 Sep; 157():155968. PubMed ID: 35872504
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
Zhao Q; Zong H; Zhu P; Su C; Tang W; Chen Z; Jin S
Exp Hematol Oncol; 2024 Jan; 13(1):6. PubMed ID: 38254219
[TBL] [Abstract][Full Text] [Related]
15. Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways.
MacLean MR; Walker OL; Arun RP; Fernando W; Marcato P
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612911
[TBL] [Abstract][Full Text] [Related]
16. ASN004, A 5T4-targeting scFv-Fc Antibody-Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical Models.
Smith RA; Zammit DJ; Damle NK; Usansky H; Reddy SP; Lin JH; Mistry M; Rao NS; Denis LJ; Gupta S
Mol Cancer Ther; 2021 Aug; 20(8):1327-1337. PubMed ID: 34045226
[TBL] [Abstract][Full Text] [Related]
17. 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
Kerk SA; Finkel KA; Pearson AT; Warner KA; Zhang Z; Nör F; Wagner VP; Vargas PA; Wicha MS; Hurt EM; Hollingsworth RE; Tice DA; Nör JE
Clin Cancer Res; 2017 May; 23(10):2516-2527. PubMed ID: 27780858
[No Abstract] [Full Text] [Related]
18. Cancer stem cells and tumorigenesis.
Zhu P; Fan Z
Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
[TBL] [Abstract][Full Text] [Related]
19. Signaling pathways in the regulation of cancer stem cells and associated targeted therapy.
Manni W; Min W
MedComm (2020); 2022 Dec; 3(4):e176. PubMed ID: 36226253
[TBL] [Abstract][Full Text] [Related]
20. A concise review on the current understanding of pancreatic cancer stem cells.
Vaz AP; Ponnusamy MP; Seshacharyulu P; Batra SK
J Cancer Stem Cell Res; 2014; 2():. PubMed ID: 26451384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
